Table 3.
SF-36 categories and DHI scores in patient who received betahistine before and after treatment
| Variables | Mean (SD) | Test statistics* | P-value | |
|---|---|---|---|---|
| Before treatment | After treatment | |||
| Categories in SF-36 | ||||
| General health perceptions | 44.3 (17.4) | 69 (15.5) | − 4.536¥ | 0.0001¥ |
| Vitality | 50.3 (14.5) | 73.7 (15.5) | − 7.547 | 0.0001 |
| Physical functioning | 48 (16.4) | 69 (13.8) | − 6.5 | 0.0001 |
| Role limitation due to physical health problems | 37.5 (31.3) | 57.5 (22.9) | − 3.839¥ | 0.0001¥ |
| Bodily pain | 45.5 (22.3) | 61 (15.5) | − 3.586 | 0.0001 |
| Emotional well-being | 37.5 (24.9) | 54.4 (16.6) | − 2.853 | 0.008 |
| Role limitation due to emotional problems | 21.1 (29.6) | 52.2 (38.8) | − 3.558 | 0.001 |
| Social functioning | 42.3 (21.2) | 62.2 (22.6) | − 3.694 | 0.001 |
| DHI | 63.5 (25.5) | 33.2 (16.3) | − 6.314 | 0.001 |
*Paired t-test or Wilcoxon
¥Wilcoxon test